Evidence map›Paper›PMID 34360837›Full record

ReviewInternational journal of molecular sciences2021

Role of Amine Neurotransmitters and Their Receptors in Skin Pigmentation: Therapeutic Implication.

Enkhmend Enkhtaivan, Chang Hoon Lee

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06138509 (Role of Peripheral Serotonin in Oculocutaneous Albinism), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06138509 recruitingnot on this mapstarted 2024, after this paper: background citation

Role of Peripheral Serotonin in Oculocutaneous Albinism

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2024 to 2026Enrolled160ConditionsOculocutaneous AlbinismArmsDosage of serotonin and metabolites, Blood parameters
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Enkhmend EnkhtaivanCollege of Pharmacy, Dongguk University, Seoul 04620, Korea.
Chang Hoon LeeCollege of Pharmacy, Dongguk University, Seoul 04620, Korea.ORCID 0000-0003-2210-0793
Dongguk University · KR

Funding

Korea Health Industry Development Institute HP20C0131National Research Foundation of Korea NRF-2018R1A5A2023127National Research Foundation of Korea NRF-2020R1A2C 3004973
6 · The paper itself

Abstract

Skin pigmentation can occur due to increased melanin, including melanocyte proliferation, melanin biosynthesis, or melanocyte migration. There are many factors that influence the melanin production process, but the role of neurotransmitters in this process is still unclear. We found that histamine and serotonin influence the different stages of melanogenesis and melanogenesis, which increase melanogenesis. Since then, several related papers have been published, and from these papers, it has been recognised that the role of neurotransmitters in skin-pigment-related diseases needs to be summarised. By introducing the role of neurotransmitters in the regulation of various pigment disorders, including vitiligo and melasma, through this review, many researchers can be expected to try to apply neurotransmitter-related agonists and antagonists as treatments for skin pigment disorders.

Indexed as

Skin PigmentationAnimalsHumansMelaninsMelanocytesMelanosisNeurotransmitter AgentsPigmentation DisordersReceptors, NeurotransmitterVitiligoMelaninsNeurotransmitter AgentsReceptors, Neurotransmitteracetylcholinedopaminehistamimemelanogenesisserotoninskin pigment abnormalityvitiligo

Identifiers

PMID34360837
PMCPMC8348573
OpenAlexW3185274933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.